METHOD FOR INCREASING ETEC CS6 ANTIGEN PRESENTATION ON CELL SURFACE AND PRODUCTS OBTAINABLE THEREOF

METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE SYSTEM FUNCTION

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROPHYLAXIS AND TREATMENT OF LYME DISEASE

INFLUENZA VIRUS VACCINES AND USES THEREOF

INFLUENZA VIRUS VACCINES AND USES THEREOF

USE OF MATRIX BOUND VESICLES (MBV) AS VACCINE ADJUVANTS

STREPTOCOCCAL VACCINES AND METHODS FOR USE

ENHANCED EXPRESSION VIA AUTOTRANSPORTERS

IMMUNOBIOTICS FOR PREVENTING BACTERIAL PNEUMONIA AND METHODS OF USING THE SAME

VACCINES AGAINST MORITELLA VISCOSA

INACTIVATED STAPHYLOCOCCUS COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

TREATMENT AND PREVENTION OF VIRAL INFECTIONS

OMPA MUTATIONS ENHANCE OMV PRODUCTION IN BORDETELLA PERTUSSIS

IDENTIFICATION OF G. PARASUIS IMMUNOGENIC PROTEINS AND SUBUNIT VACCINE COMPRISING SUCH

CELL-BASED VACCINES

VACCINATION AND ANTIBODY GENERATION PLATFORM

CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY

ANAPLASMA VACCINES AND METHODS OF USE THEREOF

IMMUNOSTIMULATORY COMPOSITION

CLOSTRIDIUM CHAUVOEI VACCINE AND METHOD OF MAKING

MULTIVALENT VACCINE COMPOSITION FOR PREVENTION OF PORCINE MYCOPLASMA AND PORCINE CIRCOVIRUS INFECTIONS

VACCINE INCLUDING NONENCAPSULATED STRAIN AS ANTIGEN

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA

Novel Adjuvant Compositions

VACCINE FOR PROTECTION AGAINST ETEC-INDUCED DIARRHEA COMPRISING DMLT

Inductor property identification for power converters

VACCINE METHOD AND COMPOSITION FOR BACTERIAL DISEASES IN INVERTEBRATES

BACTERIOPHAGES AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI

INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION

MODIFIED BACTERIUM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

INACTIVATED VACCINES & NUCLEIC ACID APTAMER THERAPEUTICS DERIVED THEREFROM

IMMUNOGENIC COMPOSITION CONTAINING AN ANTIGEN AND AN ADJUVANT COMPRISING AL-MOFS

PSORALEN-INACTIVATED NEISSERIA GONORRHOEAE VACCINES AND METHODS THEREOF

Personalized Site-Specific Immunomodulation

METHOD FOR INCREASING ETEC CS6 ANTIGEN PRESENTATION ON CELL SURFACE AND PRODUCTS OBTAINABLE THEREOF

IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SWINE DYSENTERY

Anti-Microbial Immunomodulation

TREATMENT OF CANCERS AND INFECTIOUS DISEASES WITH KILLED INTACT BACTERIA

METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE SYSTEM FUNCTION

METHOD FOR TREATING FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME

MYCOBACTERIAL IMMUNOTHERAPY FOR TREATING CANCER

CHOLERA VACCINE FORMULATION

COMPOSITIONS COMPRISING INACTIVATED MICROBES, AND METHODS FOR USE AND PRODUCTION THEREOF

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

OUTER MEMBRANE VESICLES

IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS

SARS-COV-2 RECEPTOR BINDING DOMAIN IN NATIVE OUTER MEMBRANE VESICLES

HAKIM POURCINA'S GAND ZODA-E

Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein

INFLUENZA VIRUS SURFACE PROTEIN-DERIVED RECOMBINANT HEMAGGLUTININ PROTEIN FORMING TRIMER, AND USE THEREOF

IMMUNOGENIC TREATMENT OF CANCER

VACCINES COMPRISING GLYCOENGINEERED BACTERIA

CORONAVIRUS VACCINES COMPRISING A TLR9 AGONIST

Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction

PARAPOXVIRUS FOR CONDITIONING FOR AND TREATMENT OF CORONAVIRUS INFECTIONS

USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT GESTATIONAL DIABETES MELLITUS

APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN TREATING INFECTION ASSOCIATED WITH BURN OR SCALD INJURY

COMPOSITIONS AND METHODS FOR PRODUCING ENHANCED IMMUNE RESPONSES AND RAPID ANTIBODY PRODUCTION

EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONS

VACCINE TO PREVENT MYCOPLASMAL INFECTIONS IN WATERFOWL

MYCOPLASMA BOVIS COMPOSITIONS

Vaccine Adjuvants for Antigen Delivery

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

NEW IMMUNOGENIC COMPOSITIONS

Triple vaccine for diseases caused by and

Vaccine composition against Chlamydiaceae infections

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROPHYLAXIS AND TREATMENT OF LYME DISEASE

IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY

COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING VIRAL INFECTIONS, AND METHODS OF USING THE SAME

Vaccine used for preventing toxoplasma gondii infection and preparation method therefor

VACCINE COMPOSITIONS AND ADJUVANT

Vsg-based vaccination and antibody generation platform for the treatment of diseases

Stable emulsions of bacterial antigens

CLOSTRIDIUM DIFFICILE MULTI-COMPONENT VACCINE

STREPTOCOCCAL VACCINE FORMULATIONS AND USES THEREOF

Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same

Adjuvant compositions

Vaccine for protection against ETEC-induced diarrhea comprising dmLT

Methods of treating fungal infections

Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines

Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction

Edible vaccination against microbial pathogens

Method for treating fibromyalgia and chronic fatigue syndrome

Checkpoint inhibitor and a whole cell for use in cancer therapy

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

Streptococcal vaccine

Method for increasing ETEC CS6 antigen presentation on cell surface and products obtainable thereof

Anti-microbial immunomodulation

METHODS AND COMPOSITION FOR PREVENTING AND/OR TREATING CANCER

Vaccines with enhanced immunogenicity, low allergenicity and reactogenicity

Vaccination against diabetes, obesity and complications thereof

Method for preparing a K serum with a vibrio parahaemolyticus as an antigen

Tuberculosis vaccine, preparation method therefor, and use thereof

Immunogenic compositions comprising

Mucosal adjuvants and delivery systems

Vaccine composition against infections

Hepatitis B treatment vaccine base on inactivated whole recombinant Hansenula polymorpha cells which expresses HBsAg and HBcAg

Intradermal combination vaccine against mycoplasma and porcine circovirus

Vaccine compositions for use against digital dermatitis in a mammal

PCV/mycoplasma hyopneumoniae vaccine

Immunogenic treatment of cancer

Mycoplasma hyopneumoniae vaccine

Bacteriologically-modified whole-cell tumor vaccine and method of making same

NANOPARTICLE-BASED COMPOSITIONS

Checkpoint inhibitor and a whole cell for use in cancer therapy

Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy

Checkpoint inhibitor and a whole cell for use in cancer therapy

Vaccine for protection against ETEC-induced diarrhea comprising dmLT

Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein

VACCINES AGAINST TICK-BORNE DISEASES

CHLAMYDIA NANOEMULSION VACCINE

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

Personalized Site-Specific Immunomodulation

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus

Immunomodulatory compositions and methods of use thereof

Vaccines containing swine pathogens for associated non-mixed use

YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA

Immunostimulatory preparation exhibiting antitumor activity

Method for increasing ETEC CS6 antigen presentation on cell surface and products obtainable thereof

Vaccine for intrauterine disease

Antibodies that modulate immunity to drug resistant and latent MTB infections

METHODS OF TREATING CANCER USING PARABACTEROIDES

Fungal vaccine compositions and methods of use thereof

compositions

Anti-microbial immunomodulation

Compositions and methods for the treatment or prevention of human immunodeficiency virus infection

Mucosal adjuvants and delivery systems

Immunogenic treatment of cancer

Vaccine comprising drug and parasite administration

Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg

PCV/vaccine for use with PRRSV vaccine

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

Compositions and methods for the treatment or prevention of tuberculosis

vaccine

Immunogenic compositions comprising

A COMBINATION VACCINE AGAINST PCV2 VIRUS AND MYCOPLASMA HYOPNEUMONIAE INFECTION

Influenza virus vaccines and uses thereof

Vaccine for intradermal application against PCV2 and PRRS virus infection

Combination vaccine against PCV2 and PRRS virus infection comprising albumin

Method for treating fibromyalgia and chronic fatigue syndrome

Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically thereto

METHODS AND COMPOSITIONS USING LISTERIA FOR ENHANCING IMMUNOGENICITY BY PRIME BOOST

Adjuvant compositions

Checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy

Methods and compositions related to accelerated humoral affinity

Vaccination against diabetes, obesity and complications thereof

Process for production of purified recombinant cholera toxin B (rCTB) and formulation thereon

INFLUENZA VIRUS VACCINES AND USES THEREOF

Attenuated or inactivated pathogenic for treating urogenital cancer

Immunotherapy of canine leishmaniasis

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Compositions and methods for treatment of bacterial infections

A VACCINE TO PROTECT AN MDA POSITIVE ANIMAL AGAINST A DISORDER ARISING FROM AN INFECTION WITH LAWSONIA INTRACELLULARIS

Immunological signatures and parameters predicting therapeutic responses to anti-TNF therapy

Vaccine against based on cellular components deficient in lipopolysaccharide

Methods and compositions for modulating PrfA mediated virulence gene activation in spp

VACCINE FOR INTRAUTERINE DISEASE

Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines

Immunogenic composition of killed leptospira bacteria

Vaccine containing inactivated cells of mixed with leucocidin

Vaccine composition against Chlamydiaceae infections

Edible vaccination against microbial pathogens

Modified yeast-brachyury immunotherapeutic compositions

Swine dysentery vaccine

Compositions and methods for the treatment or prevention of human immunodeficiency virus infection

VACCINE COMPRISING LACTOBACILLUS STRAINS FOR TREATING PROSTATE INFLAMMATION AND BENIGN PROSTATE HYPERPLASIAS

Inactivated Bacterial Cell Formulation

Vaccine composition for treating or preventing shigellosis

Antibodies that modulate immunity to drug resistant and latent MTB infections

NON-TYPEABLE HAEMOPHILUS INFLUENZAE VACCINES AND THEIR USES

Streptococcal vaccine

Method for increasing ETEC CS6 antigen presentation on cell surface and products obtainable thereof

Vaccine formulation, preparation method therefor and use thereof

Method of preparing bacterial ghosts from gram-positive bacteria by hydrochloric acid treatment

with an O-antigen having an extended carbohydrate chain and use thereof

Vaccine for use against subclinical infection in a pig

Vaccine for use against subclinical infection in a pig

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

Pertussis vaccines and methods of making and using

GENE DRO1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME

Adjuvant compositions

Vaccine for PCV2 and mycoplasma

PCV/mycoplasma hyopneumoniae/lawsonia intracellularis combination vaccine

Mycoplasma hyopneumoniae vaccine

Adjuvant compositions and related methods

Dual adjuvant vaccine compositions, preparation and uses

Immunotherapy composition and use thereof

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

Mucosal adjuvants and delivery systems

Vaccine preparation using ultraviolet radiation

Vaccine for intrauterine disease

Anti-microbial immunomodulation

VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE

West Nile Virus vaccine

PHOTOSENSITIZED TRYPANOSOMATIDS AND VACCINE COMPOSITIONS THEREOF

Checkpoint inhibitor and a whole cell for use in cancer therapy

Immunogenic composition of killed bacteria

Monoclonal antibodies that modulate immunity to MTB and enhance immune clearance

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Inactivated bacterial cell formulation

Immunogenic compositions comprising

Influenza virus vaccines and uses thereof

Immunomodulatory compositions and methods of use thereof

Swine Vaccine Against PRRS and Lawsonia Intracellularis

Vaccine against Lawsonia intracellularis and porcine circovirus 2

Fish vaccine

Fish vaccine

Adjuvant compositions and related methods

Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides

Yeast-based immunotherapy for Chordoma

Tissue targeted antigenic activation of the immune response to treat cancers

Method for increasing ETEC CS6 antigen presentation on cell surface and products obtainable thereof

Compositions containing amino acids, phosphate and manganese and their uses

Compositions and methods for the treatment or prevention of tuberculosis

Immunogenic compositions and methods for pigeon fever

Potomac horse fever isolates

Swine dysentery vaccine

Immunotherapy composition and use thereof

Methods and compositions using for enhancing immunogenicity by prime boost

Method of making a mycoplasma vaccine

Compositions and methods for treatment of microbial infections

Oral vaccine having improved cellular immunity induction potency

Vaccine for PCV2 and mycoplasma

Vaccine to prevent mycoplasmal infections in waterfowl

CANCER THERAPY

Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias

Compositions and methods for the treatment or prevention of human immunodeficiency virus infection

Formulations

Campylobacter vaccine

Compositions and methods for treatment of microbial infections

Nanoparticle-based compositions

Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins

Tissue targeted antigenic activation of the immune response to treat cancers

Vaccines for control of epidemic generated by markerless gene deletion

Influenza virus vaccines and uses thereof

Vaccine for intrauterine disease

Vaccine for protection against ETEC-induced diarrhea comprising dmLT

Method of treating central nervous system disorders with Borrelia burgdorferi antigen

Leptospira with increased antigenic mass

Method of treating desmocollin-3 expressing cancer with

PCV/mycoplasma hyopneumoniae/PRRS combination vaccine

vaccine

PCV/combination vaccine

VACCINE

Therapeutic agent for cancer

IMMUNOGENIC COMPOSITION COMPRISING AN INACTIVATED RECOMBINANT NON-PATHOGENIC BACTERIUM

Tuberculosis vaccine and method of using same

Liquid stable virus vaccines

Lactic acid bacterium having immunomodulatory and anti-allergic effects and pharmaceutical composition containing the same

Personalized Site-Specific Immunomodulation

Immunogenic composition of killed leptospira bacteria

SPIROCYCLIC ISOXAZOLINE DERIVATIVES FOR TREATMENT OF SEA LICE

Immunogenic composition of killed bacteria

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Vaccination by means of recombinant yeast by producing a protective humoral immune response against defined antigens

Veterinary vaccine

Inactivated mycobacteria for oral use in the prevention of tuberculosis

Compositions and methods for treatment of microbial infections

VACCINE

Fish vaccine

Influenza virus vaccines and uses thereof

Yeast-based therapeutic for chronic hepatitis B infection

vaccine serovar type four

USE OF SACCHARIDES CROSS-REACTIVE WITH BACILLUS ANTHRACIS SPORE GLYCOPROTEIN AS A VACCINE AGAINST ANTHRAX

Cancer Treatment by Immunotherapy With BCG or Antigenically Related Non-Pathogenic Mycobacteria

Enhancing immunity to tuberculosis

Immunogenic compositions comprising

West Nile Virus vaccine

Influenza virus vaccines and uses thereof

Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

lipoteichoic acid and uses thereof

Inactivating pathogens with oxidizing agents for vaccine production

Potomac horse fever isolates

Method for increasing ETEC CS6 antigen presentation on cell surface and products obtainable thereof

Compositions and methods for vaccinating cattle

Vaccine and drug delivery by intranasal application of vector and vector extracts

Bovine vaccines and methods

Compositions for canine respiratory disease complex

Liquid stable virus vaccines

Adjuvant compositions

Methods for treating liver inflammation in a subject suffering from non-alcoholic steatohepatitis

Bivalent vaccine for marine fish and method for making the same

Method of providing protective immunity against heterologous leptospira strains

Tissue targeted antigenic activation of the immune response to treat cancers

Compositions and methods to elicit immune responses against pathogenic organisms using yeast-based vaccines

Tissue targeted antigenic activation of the immune response to treat cancers

Tuberculosis vaccine and method of using same

Vaccines with live bacterial isolates for systemic administration

Use of saccharides cross-reactive with spore glycoprotein as a vaccine against anthrax

One dose vaccination against infections of pigs

ORAL VACCINE FOR AQUATIC ANIMALS

Compositions containing amino acids, phosphate and manganese and their uses

Vaccine for protection against and Porcine circo virus

Personalized site-specific immunomodulation

Immunization against disease

Vaccines comprising heat-sensitive transgenes

Vaccine for tumor immunotherapy

VACCINE AGAINST MYCOPLASMA, HYOPNEUMONIAE, SUITABLE FOR ADMINISTRATION IN THE PRESENCE OF MATERNALLY DERIVED ANTIBODIES

vaccine